Euronext Paris from
Nasdaq Global Select Market in the
Website : www.erytech.com
|Date||Total of shares composing the share capital||Total of brut (1) voting rights||
Total of net (2) voting rights
|December 31,2019||17 940 035||19 534 014||19 531 514|
|January 31, 2020||17 940 035||19 534 260||19 531 760|
(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares.
Source: Erytech Pharma S.A.